BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 35612313)

  • 1. Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases.
    Wongwiwat W; Fournier B; Bassano I; Bayoumy A; Elgueta Karstegl C; Styles C; Bridges R; Lenoir C; BoutBoul D; Moshous D; Neven B; Kanda T; Morgan RG; White RE; Latour S; Farrell PJ
    J Virol; 2022 Jun; 96(12):e0039422. PubMed ID: 35612313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases.
    Abbott RJ; Pachnio A; Pedroza-Pacheco I; Leese AM; Begum J; Long HM; Croom-Carter D; Stacey A; Moss PAH; Hislop AD; Borrow P; Rickinson AB; Bell AI
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited Genetic Susceptibility to Nonimmunosuppressed Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases in Chinese Patients.
    Guan YQ; Shen KF; Yang L; Cai HD; Zhang ML; Wang JC; Long XL; Xiong J; Gu J; Zhang PL; Xiao M; Zhang W; Zhou JF
    Curr Med Sci; 2021 Jun; 41(3):482-490. PubMed ID: 34170459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
    Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
    Hue SS; Oon ML; Wang S; Tan SY; Ng SB
    Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
    Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
    Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
    Yachie A; Kanegane H; Kasahara Y
    Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic characterization of Epstein-Barr virus-associated T/NK-cell lymphoproliferative diseases.
    Luo H; Liu D; Liu W; Jin J; Bi X; Zhang P; Gu J; Zheng M; Xiao M; Liu X; Zhou J; Wang QF
    J Allergy Clin Immunol; 2023 Apr; 151(4):1096-1109. PubMed ID: 36423698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection.
    Palser AL; Grayson NE; White RE; Corton C; Correia S; Ba Abdullah MM; Watson SJ; Cotten M; Arrand JR; Murray PG; Allday MJ; Rickinson AB; Young LS; Farrell PJ; Kellam P
    J Virol; 2015 May; 89(10):5222-37. PubMed ID: 25787276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
    Okuno Y; Murata T; Sato Y; Muramatsu H; Ito Y; Watanabe T; Okuno T; Murakami N; Yoshida K; Sawada A; Inoue M; Kawa K; Seto M; Ohshima K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Narita Y; Yoshida M; Goshima F; Kawada JI; Nishida T; Kiyoi H; Kato S; Nakamura S; Morishima S; Yoshikawa T; Fujiwara S; Shimizu N; Isobe Y; Noguchi M; Kikuta A; Iwatsuki K; Takahashi Y; Kojima S; Ogawa S; Kimura H
    Nat Microbiol; 2019 Mar; 4(3):404-413. PubMed ID: 30664667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
    Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.
    Lin N; Ku W; Song Y; Zhu J; Lu Z
    Oncologist; 2019 Sep; 24(9):e905-e913. PubMed ID: 30940744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and laboratory findings of adult Epstein-Barr virus associated T/NK lymphoproliferative disease].
    Zhang Q; Zhang HY; Zhang WL; Zhong FL; Feng J; Meng QX; Yin WH; Nie LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):953-7. PubMed ID: 23998592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
    Park S; Ko YH
    J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of Epstein-Barr Virus-Infected Lymphocyte Cell Types in Peripheral Blood Mononuclear Cells as a Valuable Diagnostic Tool in Hematological Diseases.
    Zhang P; Zeng C; Cheng J; Zhou J; Gu J; Mao X; Zhang W; Cao Y; Luo H; Xu B; Li Q; Xiao M; Zhou J
    Open Forum Infect Dis; 2019 May; 6(5):ofz171. PubMed ID: 31065564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
    Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
    Front Pediatr; 2019; 7():183. PubMed ID: 31231620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection.
    Fournier B; Boutboul D; Bruneau J; Miot C; Boulanger C; Malphettes M; Pellier I; Dunogué B; Terrier B; Suarez F; Blanche S; Castelle M; Winter S; Delecluse HJ; Molina T; Picard C; Ehl S; Moshous D; Galicier L; Barlogis V; Fischer A; Neven B; Latour S
    J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32812031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.